The Library
1530 papers on microsampling and monitoring, each with a finding paraphrased to our standard and labelled in one vocabulary. Every entry links to a legitimate copy; nothing is copied from an abstract.
5 papers labelled “cgm”, newest first.
2026
A fully remote decentralised clinical trial in Danish adults with type 2 diabetes demonstrated operational feasibility with rapid recruitment, high retention (87 percent), and excellent adherence to continuous glucose monitoring (95 percent achieving ≥70 percent data coverage) and telemedicine visits (97 percent). Activity tracker adherence was poor (12 percent) due to technical issues, but remote safety monitoring was effective with no unexpected adverse events, supporting the viability of remote diabetes management.
Operational and Clinical Insights from a Fully Decentralized Clinical Study Evaluating Protocol Adherence, Participant Satisfaction, and Connected Device Data in Individuals with Type 2 Diabetes on Different Treatment Regimens — Nørgaard et al., Diabetes technology & therapeutics (paywalled)
- dct
- wearable
- rpm
- cgm
- actigraphy
2026
In adults with type 1 diabetes, Dexcom G7 and FreeStyle Libre 3 showed high accuracy during physical activity, whereas the Simplera system was less accurate; this matters for selecting devices in decentralised monitoring.
Performance of three simultaneously used rtCGM systems around a physically active weekend camp in adults with type 1 diabetes: A prospective lab and real-world study — Sanfilippo et al., Diabetes, obesity & metabolism
- blood
- capillary
- wearable
- cgm
- multimodal
2023
Decentralised monitoring of people with type 2 diabetes using continuous glucose monitoring and a hybrid smartwatch was feasible, with high participant retention and successful collection of glucose, heart rate, activity, sleep and GPS data via a study app.
Exploring Decentralized Glucose and Behaviometric Monitoring of Persons with Type 2 Diabetes in the Setting of a Clinical Trial — Ali et al., Journal of diabetes science and technology (paywalled)
- dct
- wearable
- rpm
- cgm
- digital-biomarker
- actigraphy
2018
In 36 participants undergoing a meal challenge, non-invasive optical glucose prediction achieved a mean absolute relative difference of 14.4% compared with YSI reference values, with 100% of readings in consensus error grid zones A and B. Capillary measurements using the device's invasive component showed 9.2% MARD, demonstrating the feasibility of calibrated optical monitoring for non-invasive glucose tracking.
Evaluation of a New Noninvasive Glucose Monitoring Device by Means of Standardized Meal Experiments — Pfützner et al., Journal of diabetes science and technology (paywalled)
- blood
- liquid
- capillary
- validation
- cgm
- multimodal
2016
In children with type 1 diabetes, ambulatory glucose profile showed mean absolute relative difference of 9.56% versus laboratory random glucose and 15.07% versus capillary glucose, with linear regression coefficients of 0.93 and 0.89 respectively, indicating acceptable agreement for outpatient glycaemic monitoring.
Evaluation of accuracy of ambulatory glucose profile in an outpatient setting in children with type 1 diabetes — Hulse et al., Indian journal of endocrinology and metabolism
- blood
- liquid
- capillary
- venous-agreement
- pediatric
- cgm
- multimodal
Read from the corpus on .